COVID-19 Therapeutics II: Inhaled anti-miR against COVID-19-induced inflammatory lung injury (CoVmiR) - clinical study
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:0 publications
Grant number: 03LW0153
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Known Financial Commitments (USD)
$395,891.61Funder
Federal Ministry of Research, Technology and Space (BMFTR)Research Location
GermanyLead Research Institution
LungenClinic Grosshansdorf GmbHResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
N/A